April 19, 2022
The U.S. Securities and Exchange Commission's case against a biotechnology firm and its chief executive accused of falsely claiming regulators approved of their disinfectants for fighting COVID-19 has resulted in a civil penalty and a prohibition on trading penny stocks, according to a consent judgment approved by an Ohio federal judge.
August 19, 2021
The U.S. Securities and Exchange Commission in Ohio federal court accused a company of fooling investors by releasing press statements and social media posts that its disinfectant products, apparently launched to fight COVID-19, had been approved by the federal government.